<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We describe a rare case of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> that developed <z:hpo ids='HP_0011010'>chronic</z:hpo> myelogeneous <z:hpo ids='HP_0001909'>leukemia</z:hpo> with acquisition of Philadelphia chromosome </plain></SENT>
<SENT sid="1" pm="."><plain>The major BCR/ABL transcript was confirmed by molecular analysis </plain></SENT>
<SENT sid="2" pm="."><plain>Shortly thereafter, the patient showed transformation to blastic crisis </plain></SENT>
<SENT sid="3" pm="."><plain>Hematological remission was achieved after 3 months of treatment with <z:chebi fb="0" ids="31690">imatinib mesylate</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>The patient relapsed with additional chromosomal abnormalities and the disease became refractory to the treatment </plain></SENT>
<SENT sid="5" pm="."><plain>Acquisition of the Philadelphia chromosome is an infrequent event in <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>, and the addition of this change to the initial genetic abnormality that caused <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> may have been associated with the accelerated clinical course of this patient </plain></SENT>
</text></document>